research

A/Professor Craig Fry

contact details

  A/Professor Craig FryCraig Fry
  Health, Ethics & Policy
  Murdoch Childrens Research Institute
  Royal Children's Hospital
  Flemington Road
  Parkville Victoria 3052

  T +61 4 00 077 911
  E craig.fry@mcri.edu.au

biography

A/Prof Fry is an NHMRC Career Development Fellow (2011-14) at the Murdoch Children's Research Institute, and Principal Fellow at the Centre for Applied Philosophy and Public Ethics and Centre for Health & Society at the University of Melbourne. Craig's research is informed by training in psychology, public health and applied ethics. He has worked in a variety of environments including community, health services, university, prison, policy and research institutes.
Craig's expertise spans questionnaire and survey design, research interview conduct, methods development, applied ethics and empirical bioethics. He publishes widely and supervises students across these areas. Craig co-Edits the Health Promotion Journal of Australia, is Associate Editor of the Journal of Empirical Research on Human Research Ethics and Editorial Board member of International Journal of Drug Policy.

achievements

2010 Manuscript Sponsorship, Writing Centre for Scholars and Researchers, University of Melbourne
2006 Victorian Premier's Drug Prevention Council 2006 Travelling Fellowship
2003 Eureka Prize for Research in Ethics (Australian Museum / Australian Catholic University)
2000 Victorian Department of Human Services, Victorian Public Health Awards for Excellence and Innovation - High Commendation for public health research contributing to policy

research focus & interest

A/Prof Fry conducts research and supervises students across the following areas:

  • E-health ethics
  • Models of identity and participation in health research, practice and policy
  • Drug and alcohol use and addiction
  • Moral identity and moral agency
  • Applied health ethics
  • Research ethics and governance
  • Health research theory and methods
  • Ethical and policy implications of addiction neuroscience

publications

Irwin K & Fry CL (2007). Strengthening drug policy and practice through ethics engagement: An old challenge for a new harm reduction. International Journal of Drug Policy, 18(2), 75-83.
Barratt M, Norman J & Fry CL (2007). Positive and negative aspects of participation in illicit drug research: Implications for recruitment and ethical conduct. International Journal of Drug Policy, 18, 235-238.
Fry CL, Treloar C & Maher L. (2007). Applied communitarian ethics for harm reduction: Promoting a dialogue within the field. Drug and Alcohol Review, 26(5), 553-555.
Shearer J, Johnston J, Fry CL, Kaye S, Dillon P, Dietze P & Collins L. (2007). Contemporary cocaine use patterns and associated harms in Melbourne and Sydney, Australia. Drug and Alcohol Review, 26(5), 537-543.
Fry CL. (2008). A comprehensive evidence-based approach is needed for promoting participation in health research: A commentary on Williams. Social Science & Medicine, 66, 1457-1460.
Fry CL, Khoshnood K, Power R, Sharma M (2008). Harm reduction ethics: Acknowledging the values and beliefs behind our actions. International Journal of Drug Policy, 19(1), 1-3.
Fry CL. (2008). An important, but not the first, hepatitis C virus behavioural intervention study. AIDS, 22(2), 319.
Shearer J, Johnston J, Fry CL, Kaye S, Dillon P, Dietze P & Collins L. (2008). An Australian profile on cocaine supply. Howard Journal of Criminal Justice, 47(1), 67-80.
Degenhardt L, Kinner SA, Roxburgh A, Black E, Bruno R, Fetherston J & Fry CL. (2008). Drug use and risk among regular injecting drug users in Australia: Does age make a difference? Drug and Alcohol Review, 27(4), 357-360.
Stoové MA, Fry CL & Lintzeris N. (2008). Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): Applications for community-based HCV surveillance, education and prevention. Harm Reduction Journal, 5:12 doi:10.1186/1477-7517-5-12.
Smith B, Keleher H, Fry C (2008). Developing values, evidence and advocacy to address the social determinants of health. Health Promotion Journal of Australia, 19(3), 171-172.
Fry CL. (2008). Research participation and internal normativity: Understanding why people participate. American Journal of Bioethics, 8(10), 43-44.
Fry CL, Irwin K. (2009). Engaging the values-based ethical dilemmas in harm minimization: A response to Weatherburn. Addiction, 104, 862-63.
Fry CL. (2009). How to build a theory about empirical bioethics: Acknowledging the limitations of empirical research. American Journal of Bioethics, 9(6-7), 83-85.
Fry CL. (2009). A descriptive social neuroethics is needed to reveal lived identities. American Journal of Bioethics - Neuroscience, 9(9), 16-17.
Mounteney J, Fry CL, McKeganey N, Haugland S. (2010). Challenges of reliability and validity in the identification and monitoring of emerging drug trends. Substance Use & Misuse, 45(1-2), 266-287.
Fry CL. (2010). Critical questions we should ask in a changing Australian preventative health landscape: Competing interests, intervention limits, and permissible health identities. Health Promotion Journal of Australia, 21(3), 170-75.
Miller P, Johnston J, Dunn M, Fry CL, Degenhardt L. (2010). Comparing probability and non-probability sampling methods in ecstasy research: implications for the internet as a research tool. Substance Use & Misuse, 45(3), 437-450.
Fry CL. (2010). What does integration mean in a biopsychosocial systems approach in addiction neuroethics? American Journal of Bioethics - Neuroscience, 1(1), 51-52.
Fry CL. (2010). Ethical implications of peer-driven recruitment: Guidelines from public health research. American Journal of Bioethics, 10(3), 16-17.
Delany C, Spriggs M, Fry CL, Gillam L. (2010). The unique nature of clinical ethics in allied health paediatrics: Lessons for ethics education. Cambridge Quarterly of Healthcare Ethics, 19, 471-480.